<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Imperial_College_London_Project_Overview"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu"><UL><LI class="selected"><A href="/Team:Imperial_College_London/Project_Overview">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Imperial_College_London/Project_Overview&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Imperial_College_London/Project_Overview&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Imperial_College_London/Project_Overview&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Imperial_College_London/Project_Overview" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Imperial College London/Project Overview</H1><DIV id="bodyContent"><H3 id="siteSub">From 2009.igem.org</H3><DIV id="II09_content_wrapper"><DIV id="II09_content"><FONT face="Calibri"><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#The_Problem"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">The Problem</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Some_statistics"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Some statistics</SPAN></A></LI><LI class="toclevel-2 tocsection-3"><A href="#Project_specifications"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext">Project specifications</SPAN></A></LI></UL><LI class="toclevel-1 tocsection-4"><A href="#Our_Solution"><SPAN class="tocnumber">2</SPAN><SPAN class="toctext">Our Solution</SPAN></A></LI><LI class="toclevel-2 tocsection-5"><A href="#References"><SPAN class="tocnumber">2.1</SPAN><SPAN class="toctext">References</SPAN></A></LI><LI class="toclevel-3 tocsection-6"><A href="#Project_Tour"><SPAN class="tocnumber">2.1.1</SPAN><SPAN class="toctext">Project Tour</SPAN></A></LI></TD></TR></TBODY></TABLE><H1><SPAN class="mw-headline" id="The_Problem">The Problem</SPAN></H1><P>The inspiration behind <B><I>The E.ncapsulator</I></B> was the inherent difficulty in delivering protein pharmaceuticals to the gut. Due to the delicate nature of proteins and the highly acidic environment present in the stomach, <B>protein molecules are readily broken down - making oral drug delivery of protein pharmaceuticals very difficult </B>.</P><P>There are several diseases that are treated using oral delivery of peptides. Among these are:
<B>Malnutrition (world hunger)</B> and <B>Phenylketonuria (PKU)</B>, a disease associated with mental retardation due to insufficient ability to metabolise phenylalanine.</P><P>In this project, we chose several different potential applications to illustrate the versatility of <B><I>The E.ncapsulator</I></B>. Firstly, we chose to synthesise phenylalanine hydroxylase (PAH), an enzyme responsible for metabolism of phenylalanine - and an enzyme that is deficient in PKU patients. Secondly we chose to synthesise the enzyme cellulase, in order to derive better nutritional value from food consumed to aleviate malnutrition around the world. Finally we chose to synthesise a small bioactive pentapeptide, opiorphin. This small molecule acts very efficiently as a pain killer and anti-depressant, whilst due to its mechanism of action, remaining non-addictive. <B><I>The E.ncapsulator</I> system is a generic drug production and delivery platform. The project great offers potential for any problem that requires the delivery of polypeptide biopharmaceuticals to the lower GI tract.</B></P><H2><SPAN class="mw-headline" id="Some_statistics">Some statistics</SPAN></H2><P>In the table below we have provided some statistics of disorders requiring administration of polypeptide drugs. This highlights the need for a <B>cost-effective and implementable solution, which is what we is offered by <I>The E.ncapsulator</I>.</B></P><TABLE style="color:#CCC; background-color:#325d97;" cellpadding="6" cellspacing="0" border="3"><TBODY><TR><TH> Malnutrition (from [3])
</TH><TH> PKU (from [4-5])
</TH></TR><TR style="color:#333; background-color:#CCCCFF;"><TD> 854 million people worldwide are suffering from malnutrition (12.6% of the world population)
</TD><TD> 1 per 10,000 - 15,000 newborns are diagnosed with phenylketonuria in the USA
</TD></TR><TR style="color:#333; background-color:#CCCCFF;"><TD> 820 million in developing countries
</TD><TD> It occurs with a frequency of between 1 in 4.500 (Turkey and Ireland) and 1 in 10.000 in most of Europe although in Finland the frequency is lower at 1 in 40.000 new born babies.
</TD></TR></TBODY></TABLE><H2><SPAN class="mw-headline" id="Project_specifications">Project specifications</SPAN></H2><UL><LI><B>Synthesis:</B> The system is generic and potentially able to manufacture any type of polypeptide.
</LI><LI><B>Purification:</B> In <I><B>The E.ncapsulator</B></I>, protein production (module 1) and encapsulation (module 2) of the cells occur in the same place. This dual production and delivery platform means that there is no need for expensive downstream purification processes.
</LI><LI><B>Storage:</B> Freeze drying in the encapsulation phase and secondary encapsulation allow for storage of <B><I>The E.ncapsulator</I></B>.
</LI><LI><B>Quality Control:</B> If one cell fails to produce the protein or polypeptide of interest, it will have minimal impact on the whole system.
</LI><LI><B>Safety:</B> In order to reduce risks associated with our product, we have chosen a GRAS (generally recognised as safe) chassis. Furthermore, all the genetic material is destroyed prior ingestion to prevent any risks of horizontal gene transfer after colonisation by the cell.
</LI></UL><H1><SPAN class="mw-headline" id="Our_Solution">Our Solution</SPAN></H1><P><B><I>The E.ncapsulator</I></B> is a novel protein manufacture and delivery platform designed to overcome these difficulties. Hover over the different parts of the image below, to learn more about each module of the system:
<DL id="cartoonmap"><DT>Growth</DT><DD id="ph"><A href="https://2009.igem.org/Team:Imperial_College_London/Chemoinduction" onmouseover="haxbackground();" onmouseout="unhaxbackground();"><SPAN><DIV class="first">Growth</DIV><DIV class="rest">The cells are grown to a critical cell density, before the system is started. It allows the culture to reach a sufficient cell number before the the cells are triggered to begin protein production. This is because protein production can slow cell growth. </DIV></SPAN></A></DD><DT>Module 1: Protein Production</DT><DD id="at"><A href="https://2009.igem.org/Team:Imperial_College_London/M1" onmouseover="haxbackground();" onmouseout="unhaxbackground();"><SPAN><DIV class="first">Module 1: Protein Production</DIV><DIV class="rest">The first module is induced with IPTG, which triggers the production of the protein of interest. As part of this project we have looked into two proteins and a peptide of interest. </DIV></SPAN></A></DD><DT>Module 2: Encapsulation</DT><DD id="u"><A href="https://2009.igem.org/Team:Imperial_College_London/M2" onmouseover="haxbackground();" onmouseout="unhaxbackground();"><SPAN><DIV class="first">Module 2: Encapsulation</DIV><DIV class="rest">The second module is where the cell, after having produced the peptide of interest, produces colanic acid. This creates a protecting layer around teh bacterium to shelter it from the acidity of the stomach.</DIV></SPAN></A></DD><DT>Module 3: Genome deletion</DT><DD id="g"><A href="https://2009.igem.org/Team:Imperial_College_London/M3" onmouseover="haxbackground();" onmouseout="unhaxbackground();"><SPAN><DIV class="first">Module 3: Genome deletion</DIV><DIV class="rest">Module 3 occurs after encapsulation of the cell containing the produced peptide of interest. This module makes the bacterium non-viable. It does so by over-expressing restriction enzymes which subsequently cleave the genomic DNA into small fragments. The cell is thus unable to produce any proteins and therefore unable to survive.</DIV></SPAN></A></DD><DT>Secondary Encapsulation</DT><DD id="p"><A href="https://2009.igem.org/Team:Imperial_College_London/Manufacturing_Considerations" onmouseover="haxbackground();" onmouseout="unhaxbackground();"><SPAN><DIV class="first">Secondary Encapsulation</DIV><DIV class="rest"> Several manufacturing considerations regarding the post-processing of the culture have been investigated. Post-processing of the culture allows the polypeptide filled cells to be converted into a pharmaceutical tablet, that can be taken orally. </DIV></SPAN></A></DD><DT>Chemoinduction</DT><DD id="time"><A href="https://2009.igem.org/Team:Imperial_College_London/Chemoinduction" onmouseover="haxbackground();" onmouseout="unhaxbackground();"><SPAN><DIV class="first">Module Integration: Chemoinduction</DIV><DIV class="rest"><B>Module 1</B> is induced by the addition of a compound, IPTG. This allows the user to 'kickstart' the system once the culture has reached a sufficiently high cell density.</DIV></SPAN></A></DD><DT>Autoinduction</DT><DD id="ci"><A href="https://2009.igem.org/Team:Imperial_College_London/Autoinduction" onmouseover="haxbackground();" onmouseout="unhaxbackground();"><SPAN style="height:235px"><DIV class="first">Module Integration: Autoinduction</DIV><DIV class="rest"><B>Module 2</B> is triggered by a switch from glucose consumption to a secondary carbon source consumption. When the initial preferential carbon source (glucose) is exhausted, the system will metabolise the secondary carbon source that is available. This switch triggers the promoter that controls the start of <B>Module 2</B>. By knowing the initial concentrations of each carbon source, this acts as a programmable time delay system for the activation of encapsulation.</DIV></SPAN></A></DD><DT>Thermoinduction</DT><DD id="t5"><A href="https://2009.igem.org/Team:Imperial_College_London/Thermoinduction" onmouseover="haxbackground();" onmouseout="unhaxbackground();"><SPAN><DIV class="first">Module Integration: Thermoinduction</DIV><DIV class="rest"><B>Module 3</B> is initiated upon an increase in temperature. The system is initially grown at 28°C, at which point <B>Module 3</B> is repressed. When the temperature is raised to 42°C, this repression is blocked, triggering the start of <B>Module 3</B>. This temperature sensitive system was chosen as after encapsulation, chemical induction may be less effective due to limited diffusion.</DIV></SPAN></A></DD></DL></P><H2><SPAN class="mw-headline" id="References">References</SPAN></H2><P>[1] <A href="http://www.americanheart.org/presenter.jhtml?identifier=4551" class="external text" rel="nofollow">Diabetes Mellitus statistics</A>
[2] <A href="http://www.wrongdiagnosis.com/h/hemophilia/stats.htm" class="external text" rel="nofollow">Hemophilia statistics</A>
[3] <A href="http://www.worldhunger.org/articles/Learn/world%20hunger%20facts%202002.htm" class="external text" rel="nofollow">World Hunger statistics</A>
[4] <A href="http://www.wrongdiagnosis.com/p/phenylketonuria/stats.htm" class="external text" rel="nofollow">Phenylketonuria in the USA</A>
[5] <A href="http://www.espku.org/3.0/index.php?option=com_content&amp;task=view&amp;id=1&amp;Itemid=2" class="external text" rel="nofollow">ESPKU (European statistics)</A> 
[6] <A href="http://www.wrongdiagnosis.com/p/phenylketonuria/stats-country.htm" class="external text" rel="nofollow">More PKU statistics (browse per country)</A>
[7] <A href="http://www.chm.davidson.edu/erstevens/Michaelis/Michaelis.html" class="external text" rel="nofollow">Michaelis-Menten kinetics</A></P><CENTER><H3><SPAN class="mw-headline" id="Project_Tour">Project Tour</SPAN></H3><B>These links may be useful to browse our results and achievements: </B></CENTER><P><TABLE border="0" style="background-color:transparent;" width="100%"><TBODY><TR><TD width="20%"><CENTER><A href="https://2009.igem.org/Team:Imperial_College_London/Major_results"><B>Major Results</B></A></CENTER></TD><TD width="20%"><CENTER><A href="https://2009.igem.org/Team:Imperial_College_London/Wetlab/BioBricks"><B>Submitted Parts</B></A></CENTER></TD><TD width="20%"><CENTER><A href="https://2009.igem.org/Team:Imperial_College_London/Achievements"><B>Achievements</B></A></CENTER></TD><TD width="20%"><CENTER><A href="https://2009.igem.org/Team:Imperial_College_London/Manufacturing_Considerations"><B>Pill Manufacture</B></A></CENTER></TD><TD width="20%"><CENTER><A href="https://2009.igem.org/Team:Imperial_College_London/genealogy"><B>Genealogy</B></A></CENTER></TD><TD width="20%"><CENTER><B> </B></CENTER></TD></TR></TBODY></TABLE></P></FONT></DIV></DIV><DIV id="II09_Gaaa"><CENTER>   </CENTER></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2009.igem.org/Team:Imperial_College_London/Project_Overview">http://2009.igem.org/Team:Imperial_College_London/Project_Overview</A>&quot;</DIV></DIV></DIV><DIV id="footer-box"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Imperial_College_London/Project_Overview" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Imperial_College_London/Project_Overview" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Imperial_College_London/Project_Overview&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Imperial_College_London/Project_Overview&amp;oldid=163284" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2009.igem.org:Privacy_policy" title="2009.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2009.igem.org:General_disclaimer" title="2009.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>